{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:20:56Z","timestamp":1775697656607,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100017530","name":"Major Scientific Project of Zhejiang Laboratory","doi-asserted-by":"publisher","award":["2020ND8AD01"],"award-info":[{"award-number":["2020ND8AD01"]}],"id":[{"id":"10.13039\/501100017530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1245\/s10434-022-12107-w","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T14:02:59Z","timestamp":1658152979000},"page":"7619-7630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade"],"prefix":"10.1245","volume":"29","author":[{"given":"Yangyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"12107_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"12107_CR2","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1200\/JCO.2014.60.2532","volume":"33","author":"PL Kunz","year":"2015","unstructured":"Kunz PL. Carcinoid and neuroendocrine tumors: building on success. J Clin Oncol. 2015;33:1855\u201363.","journal-title":"J Clin Oncol."},{"key":"12107_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3109\/0284186X.2010.492791","volume":"49","author":"ET Janson","year":"2010","unstructured":"Janson ET, Sorbye H, Welin S, et al. Nordic guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol. 2010;49:740\u201356.","journal-title":"Acta Oncol."},{"key":"12107_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934\u201359.","journal-title":"Cancer."},{"key":"12107_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.anndiagpath.2009.08.002","volume":"13","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, Batich K, Hossain S, et al. Carcinoid tumors and small cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the surveillance, epidemiology, and end results program. Ann Diagn Pathol. 2009;13:378\u201383.","journal-title":"Ann Diagn Pathol."},{"key":"12107_CR6","first-page":"8218","volume":"8","author":"C Chen","year":"2015","unstructured":"Chen C, Wang L, Liu X, et al. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Int J Clin Exp Pathol. 2015;8:8218\u201326.","journal-title":"Int J Clin Exp Pathol."},{"key":"12107_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021912","volume":"99","author":"H Chu","year":"2020","unstructured":"Chu H, Zhang C, Shi Y, et al. Gallbladder neuroendocrine carcinoma: a single center experience. Medicine Baltimore. 2020;99:e21912.","journal-title":"Medicine Baltimore."},{"key":"12107_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7819-8-12","volume":"8","author":"YP Zou","year":"2010","unstructured":"Zou YP, Li WM, Liu HR, et al. Primary carcinoid tumor of the gallbladder: a case report and brief review of the literature. World J Surg Oncol. 2010;8:12.","journal-title":"World J Surg Oncol."},{"key":"12107_CR9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/PAS.0000000000001536","volume":"44","author":"SM Lee","year":"2020","unstructured":"Lee SM, Sung CO. Neuroendocrine carcinomas of the gallbladder: a clinicopathologic and immunohistochemical analysis of 34 resected cases. Am J Surg Pathol. 2020;44:1308\u201321.","journal-title":"Am J Surg Pathol."},{"key":"12107_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2147\/CMAR.S227501","volume":"12","author":"S Yan","year":"2020","unstructured":"Yan S, Wang Y, Chen X, et al. Clinical analysis of 15 cases of gallbladder neuroendocrine carcinoma and comparison with gallbladder adenocarcinoma using a propensity score-matching. Cancer Manag Res. 2020;12:1437\u201346.","journal-title":"Cancer Manag Res."},{"key":"12107_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3332\/ecancer.2021.1174","volume":"15","author":"J Ghosh","year":"2021","unstructured":"Ghosh J, Chatterjee M, Ganguly S, et al. Outcomes of metastatic neuroendocrine carcinoma of the gallbladder. Ecancermedicalscience. 2021;15:1174.","journal-title":"Ecancermedicalscience"},{"key":"12107_CR12","doi-asserted-by":"crossref","unstructured":"Gogna S, Samson D, Gachabayov M, et al. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome. Langenbecks Arch Surg. 2022;407:197\u2013206.","DOI":"10.1007\/s00423-021-02256-z"},{"key":"12107_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1530\/EC-19-0124","volume":"8","author":"D Cen","year":"2019","unstructured":"Cen D, Liu H, Wan Z, et al. Clinicopathological features and survival for gallbladder NEN: a population-based study. Endocr Connect. 2019;8:1273\u201381.","journal-title":"Endocr Connect."},{"key":"12107_CR14","volume-title":"AJCC Cancer Staging Manual","author":"D Byrd","year":"2017","unstructured":"Byrd D, Carducci M, Compton C, et al. AJCC Cancer Staging Manual. 8th edn. New York: Springer; 2017.","edition":"8"},{"key":"12107_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182\u20138.","journal-title":"Histopathology."},{"key":"12107_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","volume":"4","author":"M Omata","year":"2010","unstructured":"Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439\u201374.","journal-title":"Hepatol Int."},{"key":"12107_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00330-015-3941-7","volume":"26","author":"JH Kim","year":"2016","unstructured":"Kim JH, Eun HW, Kim YJ, et al. Pancreatic neuroendocrine tumour (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol. 2016;26:1338\u201347.","journal-title":"Eur Radiol."},{"key":"12107_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3748\/wjg.v21.i1.269","volume":"21","author":"SP Yun","year":"2015","unstructured":"Yun SP, Shin N, Seo HI. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. World J Gastroenterol. 2015;21:269\u201375.","journal-title":"World J Gastroenterol."},{"key":"12107_CR19","unstructured":"Adsay NV, La Rosa S. Neuroendocrine neoplasms of the gallbladder and bile ducts. In: WHO Classification of Tumours Editorial Board (ed) Digestive System Tumours WHO Classification of Tumours. 5th ed. IARC, Lyon, 2019, pp 292\u20134."},{"key":"12107_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00000478-200105000-00005","volume":"25","author":"A Maitra","year":"2001","unstructured":"Maitra A, Tascilar M, Hruban RH, et al. Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol. 2001;25:595\u2013601.","journal-title":"Am J Surg Pathol."},{"key":"12107_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/cncr.31124","volume":"124","author":"A Dasari","year":"2018","unstructured":"Dasari A, Mehta K, Byers LA, et al. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases. Cancer. 2018;124:807\u201315.","journal-title":"Cancer."},{"key":"12107_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2214\/AJR.18.19881","volume":"211","author":"Y Sanli","year":"2018","unstructured":"Sanli Y, Garg I, Kandathil A, et al. Neuroendocrine tumor diagnosis and management: (68)Ga-DOTATATE PET\/CT. AJR Am J Roentgenol. 2018;211:267\u201377.","journal-title":"AJR Am J Roentgenol."},{"key":"12107_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342.","journal-title":"JAMA Oncol."},{"issue":"1\u201318","key":"12107_CR24","first-page":"vii","volume":"40","author":"B Lawrence","year":"2011","unstructured":"Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40(1\u201318):vii.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"12107_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.beem.2007.01.004","volume":"21","author":"G Kloppel","year":"2007","unstructured":"Kloppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007;21:15\u201331.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"12107_CR26","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s00330-015-3600-z","volume":"25","author":"SH Kim","year":"2015","unstructured":"Kim SH, Kim SH, Kim MA, et al. CT differentiation of poorly differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas. Eur Radiol. 2015;25:1946\u201357.","journal-title":"Eur Radiol."},{"key":"12107_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/diagnostics10110881","volume":"10","author":"J Baekdal","year":"2020","unstructured":"Baekdal J, Krogh J, Klose M, et al. Limited diagnostic utility of chromogranin a measurements in workup of neuroendocrine tumors. Diagnostics Basel. 2020;10:881.","journal-title":"Diagnostics Basel."},{"key":"12107_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.annonc.2021.08.1746","volume":"32","author":"IM Modlin","year":"2021","unstructured":"Modlin IM, Kidd M, Falconi M, et al. A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility. Ann Oncol. 2021;32:1425\u201333.","journal-title":"Ann Oncol."},{"key":"12107_CR29","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1245\/s10434-021-10021-1","volume":"28","author":"IM Modlin","year":"2021","unstructured":"Modlin IM, Kidd M, Oberg K, et al. Early identification of residual disease after neuroendocrine tumor resection using a liquid biopsy multigenomic mRNA signature (NETest). Ann Surg Oncol. 2021;28:7506\u201317.","journal-title":"Ann Surg Oncol."},{"key":"12107_CR30","doi-asserted-by":"crossref","unstructured":"Cabibi D, Bellavia S, Giannone AG, et al. TTF-1\/p63-positive poorly differentiated NSCLC: a histogenetic hypothesis from the basal reserve cell of the terminal respiratory unit. Diagnostics Basel. 2020;10:25.","DOI":"10.3390\/diagnostics10010025"},{"key":"12107_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4132\/jptm.2020.06.01","volume":"54","author":"HJ Hwang","year":"2020","unstructured":"Hwang HJ, Nam SK, Park H, et al. Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer. J Pathol Transl Med. 2020;54:378\u201386.","journal-title":"J Pathol Transl Med."},{"key":"12107_CR32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","volume":"128","author":"IM Modlin","year":"2005","unstructured":"Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717\u201351.","journal-title":"Gastroenterology."},{"key":"12107_CR33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s12094-018-1996-z","volume":"21","author":"A Lamarca","year":"2019","unstructured":"Lamarca A, Frizziero M, Barriuso J, et al. Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC). Clin Transl Oncol. 2019;21:950\u20133.","journal-title":"Clin Transl Oncol."},{"key":"12107_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001240","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Wu X, Wu H, et al. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. J Immunother Cancer. 2020;8:e001240.","journal-title":"J Immunother Cancer."},{"key":"12107_CR35","first-page":"CD011746","volume":"4","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman O, Elsayed Z, Elhalawani H. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database Syst Rev. 2018;4:CD011746.","journal-title":"Cochrane Database Syst Rev."},{"key":"12107_CR36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3892\/ol.2014.2787","volume":"9","author":"X Liang","year":"2015","unstructured":"Liang X, Yan Y, Wang L, et al. First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients. Oncol Lett. 2015;9:987\u201393.","journal-title":"Oncol Lett."},{"key":"12107_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/MCG.0b013e3181d7a6d4","volume":"44","author":"KM Eltawil","year":"2010","unstructured":"Eltawil KM, Gustafsson BI, Kidd M, et al. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44:687\u201395.","journal-title":"J Clin Gastroenterol."},{"key":"12107_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40792-016-0200-3","volume":"2","author":"T Adachi","year":"2016","unstructured":"Adachi T, Haraguchi M, Irie J, et al. Gallbladder small cell carcinoma: a case report and literature review. Surg Case Rep. 2016;2:71.","journal-title":"Surg Case Rep."},{"key":"12107_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000443172","volume":"103","author":"R Garcia-Carbonero","year":"2016","unstructured":"Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103:186\u201394.","journal-title":"Neuroendocrinology."},{"key":"12107_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2967\/jnumed.118.215848","volume":"60","author":"J Zhang","year":"2019","unstructured":"Zhang J, Kulkarni HR, Singh A, et al. Peptide receptor radionuclide therapy in grade 3 neuroendocrine neoplasms: safety and survival analysis in 69 patients. J Nucl Med. 2019;60:377\u201385.","journal-title":"J Nucl Med."},{"key":"12107_CR41","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/ERC-19-0400","volume":"27","author":"H Sorbye","year":"2020","unstructured":"Sorbye H, Kong G, Grozinsky-Glasberg S. PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Endocr Relat Cancer. 2020;27:R67-77.","journal-title":"Endocr Relat Cancer."},{"key":"12107_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/pin.12029","volume":"63","author":"M Shintaku","year":"2013","unstructured":"Shintaku M, Kataoka K, Kawabata K. Mixed adenoneuroendocrine carcinoma of the gallbladder with squamous cell carcinomatous and osteosarcomatous differentiation: report of a case. Pathol Int. 2013;63:113\u20139.","journal-title":"Pathol Int."},{"key":"12107_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023271","volume":"99","author":"LJ Wen","year":"2020","unstructured":"Wen LJ, Chen JH, Xu HJ, et al. The clinical profiles, management, and prognostic factors of biliary mixed neuroendocrine nonneuroendocrine neoplasms: a systematic review of the literature. Medicine Baltimore. 2020;99:e23271.","journal-title":"Medicine Baltimore."},{"key":"12107_CR44","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/PAS.0b013e31816bf41f","volume":"32","author":"DM Maru","year":"2008","unstructured":"Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404\u201311.","journal-title":"Am J Surg Pathol."},{"key":"12107_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12022-020-09605-6","volume":"31","author":"A Sciarra","year":"2020","unstructured":"Sciarra A, Missiaglia E, Trimech M, et al. Gallbladder mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) arising in intracholecystic papillary neoplasm: clinicopathologic and molecular analysis of a case and review of the literature. Endocr Pathol. 2020;31:84\u201393.","journal-title":"Endocr Pathol."},{"key":"12107_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1385\/EP:11:4:365","volume":"11","author":"M Sakaki","year":"2000","unstructured":"Sakaki M, Hirokawa M, Sano T, et al. Gallbladder adenocarcinoma with florid neuroendocrine cell nests and extensive paneth cell metaplasia. Endocr Pathol. 2000;11:365\u201371.","journal-title":"Endocr Pathol."},{"key":"12107_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002156","volume":"94","author":"M Yang","year":"2015","unstructured":"Yang M, Ke NW, Zhang Y, et al. Survival analyses for patients with surgically resected pancreatic neuroendocrine tumors by World Health Organization 2010 grading classifications and American Joint Committee on Cancer 2010 staging systems. Medicine Baltimore. 2015;94:e2156.","journal-title":"Medicine Baltimore."},{"key":"12107_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.ejso.2021.02.005","volume":"47","author":"P Holmager","year":"2021","unstructured":"Holmager P, Willemoe GL, Nielsen K, et al. Neuroendocrine neoplasms of the appendix: characterization of 335 patients referred to the Copenhagen NET Center of Excellence. Eur J Surg Oncol. 2021;47:1357\u201363.","journal-title":"Eur J Surg Oncol."},{"key":"12107_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-020-00412-3","volume":"6","author":"F Liu","year":"2021","unstructured":"Liu F, Li Y, Ying D, et al. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Signal Transduct Target Ther. 2021;6:55.","journal-title":"Signal Transduct Target Ther."},{"key":"12107_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41389-019-0138-y","volume":"8","author":"Q Hu","year":"2019","unstructured":"Hu Q, Zhang B, Chen R, et al. ZFHX3 is indispensable for Erbeta to inhibit cell proliferation via MYC downregulation in prostate cancer cells. Oncogenesis. 2019;8:28.","journal-title":"Oncogenesis."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12107-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12107-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12107-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T04:04:56Z","timestamp":1665461096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12107-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["12107"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12107-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of this study was approved by the ethical committee of FAHZU, and the need for informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}